Pfizer asks for full FDA approval of COVID pill

Pfizer asks for full FDA approval of COVID pill

Pfizer on Thursday announced it had submitted an application to receive full approval from the Food and Drug Administration (FDA) for its COVID-19 antiviral Paxlovid for use in high-risk individual…

FDA advisers recommend updating COVID booster shots for fall

At least some U.S. adults may get updated COVID-19 shots this fall, as government advisers voted Tuesday that it’s time to tweak booster doses to better match the most recent virus variants.

Pfizer submits a new NDA to FDA for COVID-19 pill PAXLOVID

Pfizer Inc. undefined said Thursday that it has submitted a New Drug Application (NDA) for COVID-19 treatment pills PAXLOVID for patients at high risk for...

Pfizer asks for formal U.S. approval of oral COVID treatment Paxlovid

Pfizer Inc said on Thursday it is seeking full U.S. approval for its oral COVID-19 antiviral treatment Paxlovid, which is currently available under an emergency use authorization (EUA). Pfizer said it submitted a New Drug Application for Paxlovid to the Food and Drug Administration for the treatment of COVID-19 in vaccinated and unvaccinated people at high risk for progression to

Pfizer asks for formal U.S. approval of oral COVID treatment Paxlovid

Pfizer Inc said on Thursday it is seeking full U.S. approval for its oral COVID-19 antiviral treatment Paxlovid, which is currently available under an emergency use authorization (EUA). Read More

Pfizer Seeks Full FDA Approval For Covid Antiviral Pill Paxlovid

Full approval would allow Pfizer to market the drug to consumers and let it remain on the market when officials declare the Covid emergency over.